This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
According to recent research published in the journal Human Pathology, Recently, the fusion gene EML4-ALK was identified in non-small cell lung carcinoma, which could be a potential therapeutic target. We investigated the prevalence of anaplastic lymphoma kinase protein expression in these tumors by immunohistochemistry and correlated the results with data from ALK molecular studies.
We care about your feedback. Let us know how we can improve your CancerCompass experience.